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Abstract: 
 
 Elderly patients are at higher risk of venous thromboembolism, including pulmonary 
embolism. Furhtermore, clinical course is frequently more servere. Platelet parameters are of 
increasing interest in thrombosis research, including mean platelet volume, which is a 
recognized indicator of increased thrombotic activity. 
The aim of the study was to compare severity of pulmonary embolism as measured by 
computed tomography, as well as mean platelet volume in younger and elderly patients. 
 Retrospective analysis of 150 patients data was performed. Both younger and older 
patients presented with similar pulmonary embolism severity, time since onset of symptoms, 
as well as d-dimer levels. Elderly patients, however presented with significantly wider 
pulmonary artery diameter and larger mean platelet volume were observed. 
 In older patients group, even at the same severity of PE, significant differences of both 
CT-derived and platelet parameters are present. 
 
 
Introduction  
 
 Modern healthcare systems are facing the problem of aging societies with their 
morbidity, course of diseases and possible complications different from youger patients. 
Venous thromboembolism (VTE) risk increases significantly with age: Montagnana et al. 
report, that with each 10 years of age, risk of VTE increases almost twice [1]. 
 In recent years, several researches have reported significant differences in platelet 
parameters between patients with different course of pulmonary embolism [PE]. In particular 
mean platelet volume (MPV) has been observed to be significantly increased in patients with 
PE as compared with those with excluded PE [2], as well as non-survivors vs. survivors [3]. 
The purpose of this study was to compare the severity of PE in younger and older 
patients using the recognized computed tomography pulmonary angiography (CTPA) 
parameters as well as platelet volume. 
 
Material and methods 
 
  Clinical data of 227 consecutive patients (F:M = 107:120, mean age: 65,5+/-16 years, 
range: 21-97) hospitalized at Department of Cardiology of Medical University of Lublin were 
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retrospectively analyzed. By analysis of histogram of age distribution, the patients were 
divided into three tertiles. Comparison of data from youngest (Group A) and eldest group 
(Group B) has been conducted. The study protocol has been approved with a waiver of 
informed consent by local Bioethical Committee (KE-0254/41/2011). 
 In all patients, PE has been confirmed by CTPA performed with 64-row VCT scanner 
(GE Medical Systems), with a standard protocol used at our institution, i.e. scanning of the 
full chest from lung apices to costodiaphragmatic recesses, 64×0.625 mm collimation, slice 
thickness 0.625 mm, with continous reconstruction. SmartPrep was used for adjustment of the 
initiation of injection of approximately 70 mL of iodinated contrast medium (Ultravist 370, 
Bayer Healthcare, Germany), at a flow rate of 
4–5 mL/sec by automatic injector, followed by 40 mL bolus of NaCl. 
 CTPA has been evaluated by four researches with > 6 years experience in thoracic 
imaging. Qanadli score has been used to assess the severity of PE as described elsewhere [4]. 
RV/LV short axis ratio has been measured, as recommended by European Society of 
Cardiology guidelines [5]. 
 Platelet parameters evaluated within 24 hrs from the PE diagnosis have been reviewed, 
and mean platelet volume (MPV) has been analyzed in this study. 
 Statistical analysis has been performed with SPSS 16.0 statistical package. 
Quantitative parameters are presented as minimal, maximal and median. Qualitative 
parameters are presented as percentages. Chi-squre and Mann-Whitney test were used with 
p≤0.05 considered significant. 
 
Results  
 
 Study group consisted of 150 patients, Group A: 76 patients, Group B: 74 patients. 
Basic descriptive data and d-dimer test results are presented in Table 1. No siginificant 
differences of sex distribution, time since the symptoms occurence, as well as d-dimer result 
have been observed between groups. Table 2 presents PE severity as measured by CTPA as 
well as MPV. Detailed distribution of MPV in the study group is presented at Figure 1. 
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Table 1. Basic characteristics of study groups. Numbers are medians, minimal and maximal 
value or pecetages whed indicated. 
 
 Group A (n=76) Group B (n=74) p 
age [yrs] 50,0 (21,0-61,0)  81,5 (77,0 - 97,0) <0,001 
females [%] 47% 58% 0,096 
symptoms 
[days] 
3 (1-14) 4 (0-19) 0,634 
d-dimer [µg/L] 4682 (930-14060) 6146 (422 - 26954)  0,558 
 
 
 
Table 2. CT measurements and MPV  in the study groups. Numbers are medians, minimal and 
maximal value. 
 
 Group A (n=76) Group B (n=74) p 
Obstruction 
score [pts] 
20 (2-38) 17 (1-36) 0,506 
RV/LV 1,13 (0,49-2,47) 1,12 (0,54-1,86) 0,488 
PA 29,1 (20,08-43,23) 32,6 (20,03-48,18) 0,002 
MPV 8,14 (6,30 – 12,10) 8,65 (6,80 – 11,90) 0,043 
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Figure 1. MPV distribution in study groups. 
 
 
Discussion 
 
Frequency of venous thromboembolism increases with age, and it also involves less 
favorable outcomes[6]. According to Weberova et al. [7], it is the third most common cause 
of mortality after 65yrs. of age. Presentation of PE is also different in elderly, with less 
frequent or less developed deep vein thrombosis in the lower limbs [8]. 
Elderly patients frequently suffer from comorbidities, which may significantly 
complicate the course of acute pulmonary embolism. In the study group, eldelrly patients 
showed signifcantly larger PA diamter than younger group, which may indicate the tendency 
for pulmonary artery hypertension [9]. In particular, the severity of pulmonary obstruction 
was similar in both groups, which may indicate the influence of comorbitidies in elderly 
patients group. 
MPV is a recognized indicator of platelet activation and thrombotic potential[10]. 
Increase in MPV results from activation of platelets, as well as production of fresh platelets, 
which are larger[11]. Increased MPV has been recognized as risk factor of stroke [12] and 
other cardiovascular disorders, with recently suggested link between platelet activation and 
vascular inflammatory response[13]. Huang et al. [14] analyzed the utility of MPV for 
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suspected PE, and report a cutoff value of 8.45 fL to be characterized by sensitivity of 89%, 
specificity of 50%, PPV of 62% and NPV of 78%, and suggest use of MPV in combination 
with d-dimer for better identification of patients at risk. Similarly, Braekkan et al. [15] show 
1.5 times increased risk of unprovoked VTE in patients with MPV > 9.5 fL as compared with 
those with MPV < 8.5 fL. Furthermore, Kostrubiec et al. report increased MPV to be a risk 
factor of early death in the course of acute PE [3], and it also correlated with increased 
troponins. 
MPV seems to be promising factor to identify patients who require more aggresive 
treatment. Peng et al. report, that the incresed MPV is predictor of unfavorable outcome of 
trombectomy in ischemic stroke [16], while Norgaz et al. observed increased risk of 
restenosis in patients with increased MPV[17], with similiar observations by Jaster et al.[18]. 
Interestingly, recent study has shown, that in patients with cancer increased MPV was 
related with decrease in thrombosis risk, which authors explain with possible different 
mechanism leading to increased thrombosis in cancer patients [19]. 
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